ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,120Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 143

$774K Total Retail Price of All Prescriptions

Rank: 11 out of 143

587 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Delaware
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 587 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

0% of this provider’s 7,584 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

36% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$95 was the average price of a prescription from this provider, compared to $79 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Delaware
LEVOTHYROXINE SODIUM 467 440 1 3
ATORVASTATIN CALCIUM 417 415 2 7
SIMVASTATIN 244 225 3 2
SYNTHROID 236 225 4 24
AMLODIPINE BESYLATE 231 217 5 4
CRESTOR 222 206 6 17
PRAVASTATIN SODIUM 200 181 7 9
LISINOPRIL 182 178 8 1
METFORMIN HCL 179 171 9 8
FUROSEMIDE 150 145 10 6
ATENOLOL 149 143 11 11
HYDROCHLOROTHIAZIDE 147 147 12 10
ALLOPURINOL 123 119 13 39
METOPROLOL TARTRATE 122 118 14 12
WARFARIN SODIUM 119 96 15 15
OMEPRAZOLE 115 102 16 5
AZITHROMYCIN 96 91 17 31
ESCITALOPRAM OXALATE 86 86 18 46
LIPITOR 84 84 19 57
LOVASTATIN 79 79 20 50
METOPROLOL SUCCINATE 79 75 20 14
DIOVAN 79 79 20 26
PANTOPRAZOLE SODIUM 76 64 23 43
CLOPIDOGREL 74 67 24 33
TAMSULOSIN HCL 71 64 25 28
LOSARTAN POTASSIUM 67 59 26 19
FENOFIBRATE 67 57 26 109
GABAPENTIN 65 56 28 18
BENICAR 64 64 29 130
ZETIA 64 64 29 75
CLONIDINE HCL 64 64 29 120
LISINOPRIL-HYDROCHLOROTHIAZIDE 63 59 32 21
DIGOXIN 61 49 33 71
CITALOPRAM HBR 60 59 34 25
PLAVIX 58 58 35 51
ENALAPRIL MALEATE 53 53 36 114
TRAMADOL HCL 53 51 36 16
VERAPAMIL ER 51 47 38 104
AZOR 50 50 39 167
RAMIPRIL 50 48 39 106
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 18, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.